北大医药
(000788)
| 流通市值：34.27亿 | | | 总市值：34.27亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 546,908,115.95 | 617,331,063.68 | 374,371,792.05 | 426,798,453.64 |
| 应收票据及应收账款 | 1,121,606,959.26 | 1,022,878,702.94 | 1,218,783,091.96 | 1,184,950,533.51 |
| 其中：应收票据 | 25,160,029.95 | 25,342,712.19 | 19,104,451.65 | 21,610,522.94 |
| 应收账款 | 1,096,446,929.31 | 997,535,990.75 | 1,199,678,640.31 | 1,163,340,010.57 |
| 应收款项融资 | 45,024,933.71 | 36,625,301.05 | 67,685,185.63 | 91,656,729.76 |
| 预付款项 | 17,088,156.58 | 15,066,010.7 | 27,667,715.01 | 13,194,724.91 |
| 其他应收款合计 | 63,597,538.17 | 62,628,606.99 | 67,266,579.38 | 104,309,457.92 |
| 存货 | 190,808,003.61 | 188,893,796.33 | 208,541,867.03 | 221,630,056.51 |
| 一年内到期的非流动资产 | - | 736,103.66 | - | - |
| 其他流动资产 | - | - | 1,971,391.56 | 2,219,093.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,985,033,707.28 | 1,944,159,585.35 | 1,966,287,622.62 | 2,044,759,049.61 |
| 非流动资产: | | | | |
| 长期应收款 | 2,389,468.49 | 2,608,390.74 | 3,257,509.74 | 4,198,525.08 |
| 投资性房地产 | 15,356,692.99 | 15,683,431.15 | 16,010,169.31 | 16,336,907.47 |
| 固定资产 | 119,643,803.18 | 121,532,693.36 | 121,971,782.45 | 117,455,983.85 |
| 在建工程 | - | 320,000 | - | 4,835,494.45 |
| 使用权资产 | 25,489,648.37 | 30,737,185.43 | 26,370,131.82 | 31,941,664.56 |
| 无形资产 | 127,322,399.63 | 131,376,976.4 | 109,678,180.14 | 104,022,368.53 |
| 开发支出 | 17,112,323.26 | 14,879,882.47 | 19,360,593.13 | 21,308,209.69 |
| 递延所得税资产 | 10,066,914.89 | 11,370,126.39 | 7,450,819.93 | 8,227,082.7 |
| 其他非流动资产 | 17,841,503.32 | 17,855,872.33 | 57,439,682.79 | 57,637,796.01 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 335,222,754.13 | 346,364,558.27 | 361,538,869.31 | 365,964,032.34 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,320,256,461.41 | 2,290,524,143.62 | 2,327,826,491.93 | 2,410,723,081.95 |
| 流动负债: | | | | |
| 短期借款 | 30,028,416.66 | 30,028,416.67 | - | 32,038,666.66 |
| 应付票据及应付账款 | 505,416,793.63 | 471,189,231.86 | 486,106,563.4 | 541,113,930.84 |
| 其中：应付票据 | 42,007,225.55 | 42,316,751.03 | 81,629,166.43 | 104,113,058.02 |
| 应付账款 | 463,409,568.08 | 428,872,480.83 | 404,477,396.97 | 437,000,872.82 |
| 合同负债 | 10,998,786.96 | 13,677,126.32 | 11,406,339.58 | 10,730,554.68 |
| 应付职工薪酬 | 19,136,363.93 | 43,256,827.13 | 24,309,899.63 | 19,870,644.17 |
| 应交税费 | 10,169,589.72 | 13,613,814.25 | 20,014,388.4 | 11,961,275.23 |
| 其他应付款合计 | 138,449,094.21 | 152,211,099.18 | 202,023,627.28 | 252,923,118.52 |
| 应付股利 | - | - | - | 15,495,673.05 |
| 一年内到期的非流动负债 | 18,744,881.58 | 22,830,533.22 | 22,432,748.72 | 22,248,605.65 |
| 其他流动负债 | 1,429,842.32 | 1,404,362.73 | 1,482,824.1 | 1,396,792.07 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 734,373,769.01 | 748,211,411.36 | 767,776,391.11 | 892,283,587.82 |
| 非流动负债: | | | | |
| 租赁负债 | 8,185,777.98 | 10,769,985.89 | 5,910,218.62 | 11,619,105.98 |
| 递延收益 | 17,947,664.65 | 17,434,046.81 | 17,910,685.04 | 14,112,288.95 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 26,133,442.63 | 28,204,032.7 | 23,820,903.66 | 25,731,394.93 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 760,507,211.64 | 776,415,444.06 | 791,597,294.77 | 918,014,982.75 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 595,987,425 | 595,987,425 | 595,987,425 | 595,987,425 |
| 资本公积 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 |
| 盈余公积 | 62,537,482.28 | 62,537,482.28 | 62,032,824.18 | 62,032,824.18 |
| 未分配利润 | 702,697,790.73 | 657,057,240.52 | 679,733,653.86 | 636,194,060.98 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,560,395,632.89 | 1,514,755,082.68 | 1,536,926,837.92 | 1,493,387,245.04 |
| 少数股东权益 | -646,383.12 | -646,383.12 | -697,640.76 | -679,145.84 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,559,749,249.77 | 1,514,108,699.56 | 1,536,229,197.16 | 1,492,708,099.2 |
| 负债和股东权益合计 | 2,320,256,461.41 | 2,290,524,143.62 | 2,327,826,491.93 | 2,410,723,081.95 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-26 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |